Answers are grounded in this paper and cite their sources.
This study investigates a real-world multicenter cohort of patients with urinary tract cancer (UTC), with primary disease sites including the bladder, urethra, and upper tract, who enrolled for research molecular testing of their germline and tumor. The purpose of this study was to evaluate factors that could affect the likelihood of identifying a clinically actionable germline pathogenic variant (PV).
No takes yet. Share an insight, caveat, or question.
Kohlmann et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: